Skip to content

The effect of inulin on rheumatoid arthritis

The effect of inulin supplementation on inflammation status, disease severity, and physical performance in patients with rheumatoid arthritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230506058098N1
Enrollment
60
Registered
2023-05-10
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: High-Performance Inulin (HPI) inulin supplement, with a degree of polymerization or DP higher than or equal to 22, under the brand name Frutafit® TEX, a product of Sensus/Netherlands,
Oligo or polymer consists of D-fructose units with a glucose unit at the end. These compounds are found in foods such as celery, chicory, garlic, onions, wheat, bananas, soybeans, artichokes, and aspa

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 30 and 65 years Willingness to participate in the study and complete the consent form before starting the supplement therapy Not taking herbal and medicinal supplements, especially antioxidant supplements, in the three months before the start of the study

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding smoking Following a special diet Taking drugs that affect the digestive microbiome, including antibiotics, proton pump inhibitors, and probiotic and prebiotic supplements in the last three months Inflammatory bowel diseases (Crohn's and ulcerative colitis) Using traditional medicine methods in the last 3 months Infectious rheumatoid arthritis

Design outcomes

Primary

MeasureTime frame
Severity of rheumatoid arthritis. Timepoint: Measuring the severity of rheumatoid arthritis at the beginning of the study (before the start of the intervention) and 60 days after the start of taking the supplement (the end of the intervention). Method of measurement: Blood tests and questionnaires related to the severity of rheumatoid arthritis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Kafeshani

Esfahan University of Medical Sciences

kafeshani_nut@yahoo.com+98 31 3792 3169

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026